23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
3.270
+0.210 (6.86%)
At close: Dec 20, 2024, 4:00 PM
3.180
-0.090 (-2.75%)
After-hours: Dec 20, 2024, 4:44 PM EST
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $84.49 million as of December 20, 2024. Its market cap has decreased by -79.17% in one year.
Market Cap
84.49M
Enterprise Value
29.57M
1-Year Change
-79.17%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from $622.97M to $84.49M, a decrease of -86.44%. That is a compound annual growth rate of -38.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 84.49M | -80.70% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 81.40M |
| OS Therapies | 80.92M |
| Assertio Holdings | 80.49M |
| So-Young International | 79.71M |
| Entera Bio | 79.56M |
| Adlai Nortye | 78.97M |
| ALX Oncology Holdings | 78.06M |
| InspireMD | 77.73M |